Stay updated on PD-1 Inhibitor Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PD-1 Inhibitor Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-1 Inhibitor Combo in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T03:21:09.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed descriptions of a clinical study involving the PD-1 inhibitor JTX-4014 and its combination with vopratelimab for treating metastatic NSCLC. The revision number has also been updated from v2.14.4 to v2.15.0.
    Difference
    32%
    Check dated 2025-04-16T14:19:47.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T08:53:23.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:05:19.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:24:16.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:41:18.000Z thumbnail image

Stay in the know with updates to PD-1 Inhibitor Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibitor Combo in NSCLC Clinical Trial page.